Novartis to exit listed Indian arm in Rs 1,446cr deal
New Delhi: Swiss drug firm Novartis will sell its entire stake of nearly 71% in its listed Indian subsidiary for about Rs 1,446 crore to a clutch of private equity investors, led by ChrysCapital. The exit comes two years after the parent began a strategic review of its Indian subsidiary, including assessing its stake in…